期刊文献+

原发性睾丸非霍奇金淋巴瘤 被引量:1

<title>imary testicular non-Hodgkin's lymphoma
下载PDF
导出
摘要 原发性睾丸非霍奇金淋巴瘤(NHL)极少见,仅占所有:NHL的1%-2%,弥漫大B细胞淋巴瘤是最常见的病理类型。多发于60岁以上老年人。对侧睾丸受侵率高,易侵及中枢神经系统、皮肤等结外器官。ⅠE/ⅡE期病人睾丸切除术后综合治疗可降低复发率,提高生存率。晚期病人以化疗为主。对侧睾丸预防照射可降低其复发率,但中枢神经系统的预防性鞘内注药是否降低复发率还有争议。该病复发率高,预后差,国际预后指数与其预后相关。 <abstract>imary testicular NHL is a rare disease, accounting for 1%-2% of all NHL. The majority of patients have diffuse large B-cell lymphoma. Most patients are more than 60 years old. Central nervous system (CNS) and contralateral testis are most likely involved, as well as skin. For early stage patients, combined modality therapy after orchiectomy is able to decrease the recurrent rate and improve the survival rate. Patients with advanced disease are mainly treated with chemotherapy. Prophylactic radiation of the contralateral testis can successfully prevent its recurrence. Prophylactic intrathecal chemotherapy for CNS remains controversial. Patients present a high relapse rate and poor prognosis. International Prognosis Index(IPI)is associated with its prognosis.
作者 姚波 李晔雄
出处 《癌症进展》 2004年第6期462-467,共6页 Oncology Progress
关键词 睾丸 非霍奇金淋巴瘤 综合治疗 预后 <keyword>stis non-Hodgkin lymphoma combined modality therapy prognosis
  • 相关文献

参考文献26

  • 1[1]Hurley LJ, Burke CR, Shetty SK, et al. Bilateral primary non-Hodgkin's lymphoma of the testis. Urology, 1996, 47:596
  • 2[2]Niitsu N, Umeda M. Clinical features of testicular nonHodgkin's lymphoma. focus on treatment strategy. Acta Oncol,1998, 37 (7-8) :677
  • 3[3]Touroutoglou N, Dimopoulos MA, Younes A, et al. Testicular lymphoma: Late relapses and poor outcome despite doxorubicinbased therapy. J Clin Oncol, 1995, 13 (6) : 1361
  • 4[4]Tweed CS, Peck RJ, Goel S, et al. A sonographic appearance oftesticular lymphoma. Clin Radiol, 1991, 43 (5) :341
  • 5[5]Zouhair A, Weber D, Belkacemi Y, et al. Outcome and patterns of failure in testicular lymphoma: A multicenter rare cancer network study. Ⅰ nt J Radiat Oncol Biol Phys, 2002, 52:652
  • 6[6]Crellin AM, Hudson BV, Bennett MH, et al. Non-Hodgkin's lymphoma of the testis. Radiother Oncol, 1993, 27 (2) :99
  • 7[7]PectasidesD, Economopoulos T, KouvatseasG, etal. Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: The hellenic cooperative oncology group experience. Oncology, 2000, 58 (4) :286
  • 8[8]Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer, 2000, 88 (1) :154
  • 9[9]Tsutsui K, Shibamoto Y, Yamabe H, et al. A radiotherapeutic experience for localized extranodal non-Hodgkin's lymphoma:Prognostic factors and re-evaluation of treatment modality. RadiotherOncol, 1991, 21 (2) :83
  • 10[10]Roche H, Suc E, Pons A, et al. Stage ⅠE non-Hodgkin's lymphoma of the testis: A need for a brief aggressive chemotherapy. J Urol, 1989, 141 (3) :554

二级参考文献1

共引文献6

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部